22% year-on-year increase of royalty income from antifungal Cresemba®Operating profit of CHF 18.5 million and net profit of CHF 12.1 millionStrengthened balance sheet through non-dilutive repayment of
Nomination Committee Appointed for BioInvent International's Annual General Meeting 2023 theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
Lund, Sweden – December 19, 2022 – The members of the Nomination Committee for BioInvent International AB:s Annual General Meeting in 2023 have now been appointed.
The following. | December 19, 2022
Total revenues increased 4% in H1 2022 to US$96.8 million, supported by increases in physicians prescribing and number of patients Strong balance sheet and stable cash flow from RUCONEST providing